Agnès L. Auclair

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

Agnès L. Auclair, J.-C. Martel, M.B. Assié et al. · Neuropharmacology · 2013 · 262 citations · Full text

Medicine, Pharmacology, Psychiatry +17

5‐HT_2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants

Agnès L. Auclair, Candice Drouin, Susanna Cotecchia et al. · European Journal of Neuroscience · 2004 · 161 citations

Medicine, Neuroscience, Pharmacology +12

F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity

Marie‐Bernadette Assié, Laurent Bardin, Agnès L. Auclair et al. · The International Journal of Neuropsychopharmacology · 2010 · 106 citations · Full text

Medicine, Neuroscience, Pharmacology +17

D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release.

Agnès L. Auclair, Susanna Cotecchia, Jacques Glowinski et al. · PubMed · 2002 · 95 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists

Ronan Depoortère, Agnès L. Auclair, Laurent Bardin et al. · European Neuropsychopharmacology · 2010 · 90 citations

Life Sciences, Neuroscience, Pharmacology +11